Tech Company Financing Transactions
XCath Funding Round
XCath closed a $30 million Series C funding round on 3/12/2026. Investors included Crescent Enterprises and private investors.
Transaction Overview
Company Name
Announced On
3/12/2026
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series C
Investors
Crescent Enterprises (Lead Investor)
private investors (Lead Investor) (Fred Moll)
Proceeds Purpose
The company intends to use the funds to support its ongoing efforts to bring its commercially-practical endovascular robot to the market and to perform a clinical telerobotic mechanical thrombectomy.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
9330 Kirby Drive 900
Houston, TX 77054
USA
Houston, TX 77054
USA
Phone
Undisclosed
Website
Email Address
Overview
We believe our team is our greatest asset. At XCath, you're an integral part of a team dedicated to making a substantial difference in patients' lives. We value direct, open communication and believe that the best ideas can come from anywhere.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Nicholas Drysdale
Founder
Eduardo Fonseca
Browse more venture capital transactions:
Prev: 3/12/2026: SkySelect venture capital transaction
Next: 3/12/2026: Delfos Energy venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs